Dana Faber Cancer Institute

• by EVOMT
• 2021-07-27

The Dana Farber Cancer Institute (DFCI) was established in 1947 and is located in Boston's Changmu Medical Park. It is a comprehensive cancer center designated by the United States federal government and a cancer specialist hospital affiliated to Harvard Medical School. The Dana Faber Cancer Institute's adult oncology specialty ranks among the top hospitals in the United States over the years, and the treatment of childhood cancer ranks among the top in the United States over the years (US News and World Report). The Institute has been certified by the Quality of Cancer Diagnosis and Treatment Initiative (a subsidiary of the American Clinical Cancer Association) for three consecutive years due to its high-quality cancer care services in the outpatient hematology oncology department

Dana Farber Cancer Research Institute works closely with Brigham and Women's Hospital (affiliated hospital of Harvard University). In 1996, Dana Farber/Brigham Cancer Center was established by integrating the world's high-quality cancer research institute and the world's high-quality hospital. It has created 12 cancer specialties integrating comprehensive medical treatment, surgery, radiotherapy and new clinical trials, which can treat lung cancer, breast cancer, stomach cancer, esophageal cancer, colorectal cancer, liver cancer Pancreatic cancer, leukemia, multiple myeloma, nervous system tumor, prostate cancer, kidney cancer, cervical cancer, osteosarcoma, head and neck cancer, skin cancer, melanoma and other tumor diseases. The two institutions are connected by an overpass and integrated into one. Outpatients for cancer patients are generally conducted at the Dana Faber Cancer Institute, while inpatient treatment is conducted at the Bregan and Women's Hospital. From August to October 2016, Dana Faber and Brigham and Women's Cancer Center was named the best cancer care center in New England for the 16th consecutive year, ranking fourth in the United States

Currently, Dana Faber Cancer Research Institute has nearly 4000 medical and nursing personnel, providing treatment to 300000 cancer patients every year. It has cooperated with many internationally renowned research institutions and medical centers to participate in more than 700 clinical trials, and has conducted a large number of research on new cancer drugs and new treatment methods. We have made outstanding achievements in clinical aspects such as cancer gene targeting therapy, cancer immunotherapy, cancer endocrine therapy, cancer biological therapy, and cancer vaccine

Its milestone achievements include:

· Developed a test for the biomarker CA-125 of ovarian cancer

· Take the lead in developing new methods for evaluating the treatment of prostate cancer

· Developed advanced surgical techniques for brain tumors

First, perform selective internal radiation therapy on the liver

The center's treatment team is composed of multidisciplinary experts, including pathologists, oncologists, radiologists, surgeons, and other health care personnel. They develop personalized treatment plans based on each patient and their disease characteristics. For local sarcomas, they can be cured through a combination of surgery, chemotherapy, and radiation therapy; For patients with advanced or metastaticfile sarcoma, the center has also conducted a large number of clinical trials to provide treatment methods for soft tissue sarcomas and malignant osteomas (such as osteosarcoma), with the aim of improving the treatment effect as much as possible, reducing the recurrence rate, and improving the quality of life of patients

The Dana Faber Institute not only enhances the understanding, diagnosis, treatment, cure, and prevention of cancer and related diseases, but also provides professional and thoughtful care for cancer children and adults. The Institute has developed numerous projects to promote public health, especially for groups at high risk and with low service levels. It can also disseminate innovative treatment methods, new scientific research results, and new drugs to target groups throughout the United States and even the world

Sarcoma and Bone Tumor Treatment Center

The main tumors treated by this treatment center include: angiosarcoma, bone cancer, chondrosarcoma, endometrial sarcoma, osteosarcoma, synovial sarcoma, uterine sarcoma, and other tumor diseases. The center is dedicated to the pathological and imaging diagnosis of sarcoma, the application of new soft tissue and bone reconstruction techniques, and the research of new treatment methods

Dr. Demetri, Director of the Sarcoma and Bone Tumor Treatment Center at Dana Faber Cancer Institute, Director of the Ludwig Center at Dana Faber/Harvard Cancer Center, Executive Director of the Clinical Transformation Research Center at Ludwig Cancer Institute, and Professor of Medicine at Harvard Medical School. Specializing in the treatment of soft tissue sarcoma, osteosarcoma, gastrointestinal stromal tumors, etc

Dr. George is the clinical director and senior physician of the Sarcoma and Bone Tumor Treatment Center at Dana Faber Cancer Institute, and an associate professor of medicine at Harvard Medical School. Clinical expertise: soft tissue sarcoma, osteosarcoma, gastrointestinal stromal tumor

Dr. Thornton is a physician at the Sarcoma and Bone Tumor Treatment Center of Dana Faber Cancer Institute. He has obtained medical certification at Brown University Medical Center, and obtained medical certification in oncology at the Sidney Kimmel Cancer Center of Johns Hopkins Medical School. His clinical expertise is sarcoma